By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment bank Oppenheimer today cut Pacific Biosciences' 2011 EPS estimate and 2012 to 2014 revenue estimates following the company's announcement earlier this week that it was slicing its workforce by 130 positions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.